EntryPoint Capital’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
GIM
EntryPoint Capital's WST Position: Q2 2026 in Review
EntryPoint Capital increased its West Pharmaceutical (WST) stake by 45% in Q2 2026, buying an estimated $223K and bringing the position to 2,360 shares worth $847K. The position accounts for 0.21% of the portfolio, ranked #123.
EntryPoint Capital first reported a position in WST in Q1 2024 and has held it in 4 quarters since. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.
- EntryPoint Capital held 2,360 shares of West Pharmaceutical worth $847K as of Q2 2026.
- EntryPoint Capital bought 729 West Pharmaceutical shares in Q2 2026, an estimated $223K.
- West Pharmaceutical made up 0.21% of EntryPoint Capital's portfolio in Q2 2026, its #123 holding.
- EntryPoint Capital first reported a position in West Pharmaceutical in Q1 2024 and has held it in 4 quarters since.
- 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.
Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.